The benefits of novel therapies in cancer treatment are substantial. They offer improved specificity in targeting cancer cells, reduced side effects, and the potential for long-term remission. For example, patients with advanced melanoma have experienced significant survival benefits from immunotherapy, while targeted therapies have transformed the treatment of cancers with specific genetic mutations.
